IP Library › Assignment 051119/0089
Patent Assignment
Reel/Frame 051119/0089

Security Interest

Recorded: 2019-11-26 Pages: 11
Assignors
AKEBIA THERAPEUTICS, INC.
Executed: 2019-11-25
KERYX BIOPHARMACEUTICALS, INC.
Executed: 2019-11-25
Assignee
BIOPHARMA CREDIT PLC
51 NEW NORTH ROAD, C/O BEAUFORT HOUSE, EXETER EX4 4EP, UNITED KINGDOM
Covered Properties (6)
Ferric Citrate Dosage Forms
Patent: 9,387,191 →
Application: 13/255,326 →
Publication: US 2012/0115945
Ferric Citrate Dosage Forms
Application: 15/159,008 →
Publication: US 2016/0263075
Use of Ferric Citrate in the Treatment of Iron-Deficiency Anemia
Application: 15/553,348 →
Publication: US 2018/0071243
Use of Ferric Citrate in the Treatment of Chronic Kidney Disease Patients
Application: 16/154,268 →
Publication: US 2019/0269645
Use of Ferric Citrate in the Treatment of and the Reduction of Mortality and Morbidity Related to Adverse Cardiac Events in Chronic Kidney Disease Patients
Application: 16/216,772 →
Publication: US 2019/0307791
Ferric Citrate Dosage Forms
Application: 16/376,907 →
Publication: US 2020/0215019
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 20, 2011
From: LE, HENRY TRONG
To: KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 027094/0971 →
Assignment of Assignor's Interest Feb 21, 2018
From: PORADOSU, ENRIQUE; BENTSUR, RON; SHEMESH, SHAY DAVID
To: KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 044985/0606 →
Assignment of Assignor's Interest May 23, 2018
From: LE, HENRY TRONG
To: KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 045886/0236 →
Assignment of Assignor's Interest Oct 21, 2019
From: LE, HENRY TRONG
To: KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 050771/0356 →
Assignment of Assignor's Interest Oct 21, 2019
From: PORADOSU, ENRIQUE; OLIVIERO, III, JAMES F.; BENTSUR, RON
To: KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 050771/0345 →
Security Interest Apr 2, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 052295/0662 →
Second Amended and Restated Intellectual Property Security Agreement Sep 2, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 053671/0221 →
Third Amended and Restated Intellectual Property Security Agreement Sep 10, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 054173/0451 →
Fourth Amended and Restated Intellectual Property Security Agreement Dec 17, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 054793/0455 →
Fifth Amended and Restated Intellectual Property Security Agreement Mar 30, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 055776/0491 →
Sixth Amended and Restated Intellectual Property Security Agreement Jun 11, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 056544/0468 →
Seventh Amended and Restated Intellectual Property Security Agreement Sep 12, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 057474/0770 →
Security Interest Dec 15, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 058399/0055 →
Assignment of Assignor's Interest Mar 30, 2022
From: PORADOSU, ENRIQUE; OLIVIERO III, JAMES F.; BENTSUR, RON
To: KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 059438/0355 →
Tenth Amended and Restated Intellectual Property Security Agreement Jun 16, 2022
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 060529/0168 →
Eleventh Amended and Restated Intellectual Property Security Agreement Aug 22, 2022
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 061297/0238 →
Twelfth Amended and Restated Intellectual Property Security Agreement Nov 29, 2022
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 062012/0561 →
Thirteenth Amended and Restated Intellectual Property Security Agreement Mar 29, 2023
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 063189/0065 →
Fifteenth Amended and Restated Intellectual Property Security Agreement Jan 4, 2024
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 066205/0143 →
Termination and Release of Security Interest in Patents Jan 29, 2024
From: BIOPHARMA CREDIT PLC
To: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 066377/0741 →
Security Interest Jan 29, 2024
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: KREOS CAPITAL VII (UK) LIMITED
Reel/Frame 066377/0654 →
Termination and Release of Security Interest in Patents Jun 25, 2024
From: BIOPHARMA CREDIT PLC
To: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 067839/0134 →